Tecnandina’s Ecuador Facility Receives ANVISA Certification

The Grünenthal Group announced on Oct. 1, 2015 that its Tecnandina manufacturing plant in Ecuador has received certification from the Regulatory Authority of Brazil (ANVISA), making it the first production plant in Ecuador to receive ANVISA certification. The certification will allow the company to export pharmaceutical products to Brazil.

Tecnandina SA belongs to the Grünenthal Group, a research-based, pharmaceutical company headquartered in Aachen, Germany.taht offers contract manufacturing from five independent production plants throughout Europe and Latin America. The company manufactures and exports to 17 countries in Central and South America, Switzerland, and the Andean countries.

Source: Grünenthal Group